David J. Katzoff, Chief Financial Officer at Alzamend Neuro, Inc. (ALZN), bought 5,000 shares at $1.01 ($5K) on 2025-03-21, disclosed to the SEC on 2025-03-24.
Open-market purchase of $5k ALZN by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |